These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291 [TBL] [Abstract][Full Text] [Related]
9. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749 [TBL] [Abstract][Full Text] [Related]
10. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation. Zwald FO; Spratt M; Lemos BD; Veledar E; Lawrence C; Marshall Lyon G; Chen SC Dermatol Surg; 2012 Aug; 38(8):1369-74. PubMed ID: 22551390 [TBL] [Abstract][Full Text] [Related]
20. The role of voriconazole in the treatment of central nervous system blastomycosis. Ta M; Flowers SA; Rogers PD Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]